Table 4.

Prevalence ratios and 95% confidence intervals of urinary symptom severity and measures of urinary incontinence among 5990 men with or without prostate cancer^*

		PCa treatment, n = 706
	No PCa, n = 5284	Observation, n = 42	Surgery, n = 362	Radiation therapy, n = 204	ADT, n = 68	Other, n = 30
AUA-SI ≥8
PR	Ref	1.07	0.76	1.06	1.23	0.58
95% CI		0.84–1.37	0.66–0.87	0.92–1.22	1.05–1.45	0.34–0.98
p value		0.59	0.001	0.41	0.001	0.04
AUA-SI ≥20
PR	Ref	1.66	0.58	1.23	1.72	0.39
95% CI		0.79–3.51	0.34–0.98	0.79–1.92	1.01–2.91	0.06–2.42
p value		0.18	0.04	0.36	0.04	0.31
AUA-SI urinary bother score ≥3
PR	Ref	1.33	1.25	1.12	1.50	0.78
95% CI		1.00–1.78	1.10–1.42	0.94–1.33	1.26–1.79	0.48–1.25
p value		0.05	0.0008	0.19	<0.0001	0.30
Urinary control: any leaking/lack of control
PR	Ref	1.37	2.10	1.20	1.26	0.42
95% CI		1.04–1.79	1.95–2.26	1.03–1.40	1.01–1.57	0.19–0.93
p value		0.02	<0.0001	0.02	0.04	0.03
Leaking frequency at least once per day vs less than once per day
PR	Ref	2.11	4.41	1.49	2.02	0.61
95% CI		1.22–3.65	3.79–5.13	1.06–2.08	1.31–3.13	0.16–2.30
p value		0.007	<0.0001	0.02	0.002	0.50
Extent of problem with leaking: any size problem vs no problem
PR	Ref	1.57	2.11	1.19	1.30	0.58
95% CI		1.20–2.06	1.93–2.31	0.99–1.42	1.02–1.66	0.29–1.20
p value		0.001	< 0.0001	0.06	0.04	0.14

PCa = prostate cancer; ADT = androgen-deprivation therapy; AUA-SI = American Urological Association Symptom Index; PR = prevalence ratio; CI = confidence interval; Ref = reference.

^*Model adjusted for age, previous benign prostatic hyperplasia diagnosis, self-reported health, and smoking status.